A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report

Filocamo, G; Consolaro, Alessandro; Schiappapietra, Benedetta; Dalprà, Sara; Lattanzi, Bianca; Magni‐Manzoni, Silvia; Ruperto, Nicolino; Pistorio, Angela; Pederzoli, Silvia; Civino, Adele; Guseinova, Dinara; Masala, Ester; Viola, Stefania; Martini, Alberto; Ravelli, Angelo

doi:10.3899/jrheum.100930

Cited by 155 publications

(126 citation statements)

References 21 publications

(37 reference statements)

Supporting

Mentioning

121

Contrasting

Unclassified

Order By: Relevance

“…This clinical database included 609 children who met the International League of Associations for Rheumatology (ILAR) criteria for JIA (11) and had undergone a total of 1,814 visits at the study center between March 2007 and December 2009. The clinical features of these patients have been described previously (10,12). Children with systemic arthritis (n ϭ 46), rheumatoid factor-positive (n ϭ 9) and rheumatoid factor-negative (n ϭ 138) polyarthritis, or extended oligoarthritis (n ϭ 96) were included in the functional polyarthritis category.…”

Section: Study Population Used For Selection Of Cutoff Valuesmentioning

confidence: 99%

Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three‐Variable Juvenile Arthritis Disease Activity Score

Consolaro

Negro

Gallo

et al. 2014

Arthritis Care & Research

Self Cite

137

131

View full text Add to dashboard Cite

Objective. To determine cutoff values for defining the states of inactive disease (ID), low disease activity (LDA; or minimal disease activity), moderate disease activity (MDA), and high disease activity (HDA) using the clinical (3-variable) Juvenile Arthritis Disease Activity Score (cJADAS). Methods. For selection of cutoffs, data from a clinical database including 609 children with juvenile idiopathic arthritis (JIA) were used. Optimal cutoffs were determined against external criteria by calculating the 75th and 90th percentile (for ID and LDA) and 10th and 25th percentile (for HDA) of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included definitions for ID and LDA cutoffs and therapeutic decisions for HDA cutoffs. MDA cutoffs were set at the score interval in-between LDA and HDA cutoffs. Crossvalidation was performed using 2 JIA patient samples (n ‫؍‬ 485) and was based on assessment of construct and discriminant validity. Results. The selected cutoffs were as follows: <1 for ID in both oligoarthritis and polyarthritis; <1.5 and <2.5 for LDA in oligoarthritis and polyarthritis, respectively; 1.51-4 and 2.51-8.5 for MDA in oligoarthritis and polyarthritis, respectively; and >4 and >8.5 for HDA in oligoarthritis and polyarthritis, respectively. In crossvalidation analyses, the cutoffs showed a strong ability to discriminate between disease activity states defined subjectively by physicians and parents, levels of pain, and presence/absence of functional impairment and disease damage. Conclusion. Cutoff values for classifying various disease states in nonsystemic JIA using the cJADAS were developed. The cutoffs revealed good measurement characteristics in crossvalidation analyses and are suited for application in clinical practice and research.

show abstract

Section: Study Population Used For Selection Of Cutoff Valuesmentioning

confidence: 99%

Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three‐Variable Juvenile Arthritis Disease Activity Score

Consolaro

Negro

Gallo

et al. 2014

Arthritis Care & Research

Self Cite

137

131

View full text Add to dashboard Cite

show abstract

“…Over the past 3 decades, several epidemiologic surveys have documented a remarkable, yet unexplained, disparity in the prevalence of JIA subtypes among different geographic areas or racial/ethnic groups 5,6,7,8,9,10,11,12,13 . In Western countries, the most common category is oligoarthritis, but this form is rare in India, New Zealand, The Middle East, and South Africa, where polyarthritis predominates.…”

mentioning

confidence: 99%

Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas — Key to Understanding Etiology and Genetic Factors?

Consolaro

Ravelli

2016

J Rheumatol

Self Cite

View full text Add to dashboard Cite

“…A multidimensional assessment questionnaire was proposed including physical, psychosocial and compliance aspects (JAMAR) (64). The JAMAR includes 15 parent or patient-centered measurements or items that assess well-being, pain, functional status, health-related quality of life, morning stiffness, disease activity, disease status and course, joint disease, extra-articular symptoms, side effects of medications, therapeutic compliance, and satisfaction with illness outcome.…”

Section: Different Scoring Methodsmentioning

confidence: 99%

Transition of Care in Rheumatology: Managing the Rheumatic Patient from Childhood to Adulthood

Pelt¹,

Wulffraat²

2012

Insights and Perspectives in Rheumatology

View full text Add to dashboard Cite

A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report

Abstract: The development of the JAMAR introduces a new approach in pediatric rheumatology practice. This new questionnaire may help enhance the quality of care of children with JIA.

Cited by 155 publications

References 21 publications

Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three‐Variable Juvenile Arthritis Disease Activity Score

Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three‐Variable Juvenile Arthritis Disease Activity Score

Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas — Key to Understanding Etiology and Genetic Factors?

Transition of Care in Rheumatology: Managing the Rheumatic Patient from Childhood to Adulthood

Contact Info

Product

Resources

About